 | | KYG | | Name: | (1R,2R,3S,4R,5R,6S)-4-{[(S)-[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-3,5,6-trihydroxycyclohexane-1,2-diyl bis[dihydrogen (phosphate)] | | Formula: | C9 H21 O17 P3 | | SMILES: | OP(OCC(CO)O)(=O)OC1C(O)C(C(C(C1O)O)OP(O)(O)=O)OP(=O)(O)O | | InChi: | InChI=1S/C9H21O17P3/c10-1-3(11)2-23-29(21,22)26-7-4(12)5(13)8(24-27(15,16)17)9(6(7)14)25-28(18,19)20/h3-14H,1-2H2,(H,21,22)(H2,15,16,17)(H2,18,19,20)/t3-,4+,5-,6-,7+,8+,9+/m0/s1 | | Definition date: | 2019-01-24 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | (1R,2R,3S,4R,5R,6S)-4-{[(S)-[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-3,5,6-trihydroxycyclohexane-1,2-diyl bis[dihydrogen (phosphate)] |
|
 | | 71O | | Name: | pyrimidin-2-ol | | Formula: | C4 H4 N2 O | | SMILES: | c1ccnc(n1)O | | InChi: | InChI=1S/C4H4N2O/c7-4-5-2-1-3-6-4/h1-3H,(H,5,6,7) | | Definition date: | 2016-08-11 | | Last modified: | 2019-12-20 | | Release date: | 2019-12-25 | | Identifier: | pyrimidin-2-ol |
|
 | | LFY | | Name: | 1-ethyl-N-[(4-fluorophenyl)methyl]-1H-imidazole-4-carboxamide | | Formula: | C13 H14 F N3 O | | SMILES: | n2(cnc(C(NCc1ccc(F)cc1)=O)c2)CC | | InChi: | InChI=1S/C13H14FN3O/c1-2-17-8-12(16-9-17)13(18)15-7-10-3-5-11(14)6-4-10/h3-6,8-9H,2,7H2,1H3,(H,15,18) | | Definition date: | 2019-02-22 | | Last modified: | 2019-05-03 | | Release date: | 2019-05-08 | | Identifier: | 1-ethyl-N-[(4-fluorophenyl)methyl]-1H-imidazole-4-carboxamide |
|
 | | E6N | | Name: | (4~{a}~{S},8~{a}~{S})-4-[4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl]-2-[1-(3-nitroimidazo[1,2-b]pyridazin-6-yl)piperidin-4-yl]-4~{a},5,6,7,8,8~{a}-hexahydrophthalazin-1-one | | Formula: | C34 H37 N7 O6 | | SMILES: | COc1ccccc1COc2cc(ccc2OC)C3=NN(C4CCN(CC4)c5ccc6ncc(n6n5)[N+]([O-])=O)C(=O)[CH]7CCCC[CH]37 | | InChi: | InChI=1S/C34H37N7O6/c1-45-27-10-6-3-7-23(27)21-47-29-19-22(11-12-28(29)46-2)33-25-8-4-5-9-26(25)34(42)39(37-33)24-15-17-38(18-16-24)31-14-13-30-35-20-32(41(43)44)40(30)36-31/h3,6-7,10-14,19-20,24-26H,4-5,8-9,15-18,21H2,1-2H3/t25-,26-/m0/s1 | | Definition date: | 2018-02-20 | | Last modified: | 2019-03-15 | | Release date: | 2019-03-20 | | Identifier: | (4~{a}~{S},8~{a}~{S})-4-[4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl]-2-[1-(3-nitroimidazo[1,2-b]pyridazin-6-yl)piperidin-4-yl]-4~{a},5,6,7,8,8~{a}-hexahydrophthalazin-1-one |
|
 | | DS1 | | Name: | 2-aminopyrimidin-5-ol | | Formula: | C4 H5 N3 O | | SMILES: | c1c(O)cnc(n1)N | | InChi: | InChI=1S/C4H5N3O/c5-4-6-1-3(8)2-7-4/h1-2,8H,(H2,5,6,7) | | Definition date: | 2017-11-02 | | Last modified: | 2018-11-02 | | Release date: | 2018-11-07 | | Identifier: | 2-aminopyrimidin-5-ol |
|
 | | BOD | | Name: | 5-{4-[3-(2-methoxypyrimidin-5-yl)phenyl]piperazin-1-yl}pyrimidine-2,4-diamine | | Formula: | C19 H22 N8 O | | SMILES: | c1(c(cnc(N)n1)N4CCN(c2cc(ccc2)c3cnc(nc3)OC)CC4)N | | InChi: | InChI=1S/C19H22N8O/c1-28-19-23-10-14(11-24-19)13-3-2-4-15(9-13)26-5-7-27(8-6-26)16-12-22-18(21)25-17(16)20/h2-4,9-12H,5-8H2,1H3,(H4,20,21,22,25) | | Definition date: | 2017-08-17 | | Last modified: | 2018-08-17 | | Release date: | 2018-08-22 | | Identifier: | 5-{4-[3-(2-methoxypyrimidin-5-yl)phenyl]piperazin-1-yl}pyrimidine-2,4-diamine |
|
 | | CVV | | Name: | N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide | | Formula: | C27 H27 I N2 O3 | | SMILES: | N(C4C=CC1C2Cc6ccc(c5c6C1(CCN2CC3CC3)C4O5)O)C(c7cc(ccc7)I)=O | | InChi: | InChI=1S/C27H27IN2O3/c28-18-3-1-2-17(12-18)26(32)29-20-8-7-19-21-13-16-6-9-22(31)24-23(16)27(19,25(20)33-24)10-11-30(21)14-15-4-5-15/h1-3,6-9,12,15,19-21,25,31H,4-5,10-11,13-14H2,(H,29,32)/t19-,20+,21+,25-,27-/m0/s1 | | Definition date: | 2017-10-04 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide |
|
 | | 77C | | Name: | 2,4-diamino-6-{[(S)-[5-chloro-8-fluoro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl](cyclopropyl)methyl]amino}pyrimidine-5-carbonitrile | | Formula: | C22 H17 Cl F N9 O | | SMILES: | C4(=O)c1c(c(ccc1Cl)F)N=C(C(C2CC2)Nc3c(C#N)c(nc(n3)N)N)N4c5cccnc5 | | InChi: | InChI=1S/C22H17ClFN9O/c23-13-5-6-14(24)17-15(13)21(34)33(11-2-1-7-28-9-11)20(30-17)16(10-3-4-10)29-19-12(8-25)18(26)31-22(27)32-19/h1-2,5-7,9-10,16H,3-4H2,(H5,26,27,29,31,32)/t16-/m0/s1 | | Definition date: | 2016-09-08 | | Last modified: | 2016-12-22 | | Release date: | 2016-12-28 | | Identifier: | 2,4-diamino-6-{[(S)-[5-chloro-8-fluoro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl](cyclopropyl)methyl]amino}pyrimidine-5-carbonitrile |
|
 | | 66X | | Name: | N-{(3S)-1-[2-(methylamino)pyrimidin-4-yl]pyrrolidin-3-yl}-N'-{4-[(morpholin-4-yl)methyl]-3-(trifluoromethyl)phenyl}urea | | Formula: | C22 H28 F3 N7 O2 | | SMILES: | C1C(CCN1c2ccnc(NC)n2)NC(Nc3cc(c(cc3)CN4CCOCC4)C(F)(F)F)=O | | InChi: | InChI=1S/C22H28F3N7O2/c1-26-20-27-6-4-19(30-20)32-7-5-17(14-32)29-21(33)28-16-3-2-15(18(12-16)22(23,24)25)13-31-8-10-34-11-9-31/h2-4,6,12,17H,5,7-11,13-14H2,1H3,(H,26,27,30)(H2,28,29,33)/t17-/m0/s1 | | Definition date: | 2016-02-09 | | Last modified: | 2016-04-15 | | Release date: | 2016-04-20 | | Identifier: | N-{(3S)-1-[2-(methylamino)pyrimidin-4-yl]pyrrolidin-3-yl}-N'-{4-[(morpholin-4-yl)methyl]-3-(trifluoromethyl)phenyl}urea |
|
 | | 5TW | | Name: | 3-oxo-23,24-bisnorchol-4-en-22-oyl-CoA | | Formula: | C43 H66 N7 O18 P3 S | | SMILES: | C[CH]([CH]1CC[CH]2[CH]3CCC4=CC(=O)CC[C]4(C)[CH]3CC[C]12C)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)CO[P](O)(=O)O[P](O)(=O)OCC5OC(C(O)C5O[P](O)(O)=O)n6cnc7c(N)ncnc67 | | InChi: | InChI=1S/C43H66N7O18P3S/c1-23(27-8-9-28-26-7-6-24-18-25(51)10-13-42(24,4)29(26)11-14-43(27,28)5)40(56)72-17-16-45-31(52)12-15-46-38(55)35(54)41(2,3)20-65-71(62,63)68-70(60,61)64-19-30-34(67-69(57,58)59)33(53)39(66-30)50-22-49-32-36(44)47-21-48-37(32)50/h18,21-23,26-30,33-35,39,53-54H,6-17,19-20H2,1-5H3,(H,45,52)(H,46,55)(H,60,61)(H,62,63)(H2,44,47,48)(H2,57,58,59)/t23-,26-,27+,28-,29-,30?,33?,34?,35?,39?,42-,43+/m0/s1 | | Definition date: | 2015-12-01 | | Last modified: | 2016-02-12 | | Release date: | 2016-02-17 | | Identifier: | ~{S}-[2-[3-[[4-[[[(2~{R},3~{S},4~{R},5~{S})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] (2~{S})-2-[(8~{S},9~{S},10~{R},13~{S},14~{S},17~{R})-10,13-dimethyl-3-oxidanylidene-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]propanethioate |
|
 | | 4Y7 | | Name: | 4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-pyrazolo[4,3-b]pyridin-3-yl}-5-fluoro-2-hydroxybenzoic acid | | Formula: | C21 H10 Cl F4 N3 O4 | | SMILES: | c4cc(C(F)(F)F)c(C(n3nc(c1cc(c(C(=O)O)cc1F)O)c2ncccc23)=O)c(c4)Cl | | InChi: | InChI=1S/C21H10ClF4N3O4/c22-12-4-1-3-11(21(24,25)26)16(12)19(31)29-14-5-2-6-27-18(14)17(28-29)9-8-15(30)10(20(32)33)7-13(9)23/h1-8,30H,(H,32,33) | | Definition date: | 2015-06-19 | | Last modified: | 2015-12-11 | | Release date: | 2015-12-16 | | Identifier: | 4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-pyrazolo[4,3-b]pyridin-3-yl}-5-fluoro-2-hydroxybenzoic acid |
|
 | | 3GQ | | Name: | benzene-1,2,3-tricarboxylic acid | | Formula: | C9 H6 O6 | | SMILES: | O=C(O)c1cccc(C(=O)O)c1C(=O)O | | InChi: | InChI=1S/C9H6O6/c10-7(11)4-2-1-3-5(8(12)13)6(4)9(14)15/h1-3H,(H,10,11)(H,12,13)(H,14,15) | | Definition date: | 2014-08-19 | | Last modified: | 2014-12-05 | | Release date: | 2014-12-10 | | Identifier: | benzene-1,2,3-tricarboxylic acid |
|
 | | NF5 | | Name: | 4-bromo-N-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)benzamide | | Formula: | C17 H17 Br N2 O | | SMILES: | Brc1ccc(cc1)C(=O)Nc2cc3c(cc2)CCNCC3 | | InChi: | InChI=1S/C17H17BrN2O/c18-15-4-1-13(2-5-15)17(21)20-16-6-3-12-7-9-19-10-8-14(12)11-16/h1-6,11,19H,7-10H2,(H,20,21) | | Definition date: | 2014-05-13 | | Last modified: | 2014-10-03 | | Release date: | 2014-10-08 | | Identifier: | 4-bromo-N-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)benzamide |
|
 | | NCP | | Name: | CIS-DIAMINODICHLOROPLATINUM | | Formula: | Cl2 H4 N2 Pt | | SMILES: | Cl[Pt](Cl)(N)N | | InChi: | InChI=1S/2ClH.2H2N.Pt/h2*1H | | Definition date: | 2005-07-28 | | Last modified: | 2014-07-25 | | Identifier: | platinum(4+) chloride azanide (1:2:2) |
|
 | | 8E9 | | Name: | 1-AMINO-4-(3-METHYLPHENYL)AMINO-9,10-DIOXO-9,10-DIHYDROANTHRACENE-2-SULFONATE | | Formula: | C21 H16 N2 O5 S | | SMILES: | O=S(=O)(O)c3cc(c2C(=O)c1ccccc1C(=O)c2c3N)Nc4cc(ccc4)C | | InChi: | InChI=1S/C21H16N2O5S/c1-11-5-4-6-12(9-11)23-15-10-16(29(26,27)28)19(22)18-17(15)20(24)13-7-2-3-8-14(13)21(18)25/h2-10,23H,22H2,1H3,(H,26,27,28) | | Definition date: | 2013-10-29 | | Last modified: | 2014-04-16 | | Release date: | 2014-02-12 | | Identifier: | 1-amino-4-[(3-methylphenyl)amino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid |
|
 | | 2RK | | Name: | 4-[(5Z)-5-(1-nitroso-2,3-dihydro-5H-inden-5-ylidene)-2-(piperidin-4-yl)-3,5-dihydro-4H-imidazol-4-ylidene]-1,4-dihydropyridine | | Formula: | C22 H23 N5 O | | SMILES: | O=NC2=C1C=C/C(C=C1CC2)=C4/N=C(NC/4=C3C=CNC=C3)C5CCNCC5 | | InChi: | InChI=1S/C22H23N5O/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15/h1,3,5-6,9-10,13,15,23-24H,2,4,7-8,11-12H2,(H,25,26)/b21-17- | | Definition date: | 2014-01-13 | | Last modified: | 2014-02-28 | | Release date: | 2014-03-05 | | Identifier: | 4-[(5Z)-5-(1-nitroso-2,3-dihydro-5H-inden-5-ylidene)-2-(piperidin-4-yl)-3,5-dihydro-4H-imidazol-4-ylidene]-1,4-dihydropyridine |
|
 | | Q1A | | Name: | 1-[4-(1-aminoisoquinolin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea | | Formula: | C23 H23 N5 O2 | | SMILES: | O=C(Nc1noc(c1)C(C)(C)C)Nc4ccc(c3c2ccnc(N)c2ccc3)cc4 | | InChi: | InChI=1S/C23H23N5O2/c1-23(2,3)19-13-20(28-30-19)27-22(29)26-15-9-7-14(8-10-15)16-5-4-6-18-17(16)11-12-25-21(18)24/h4-13H,1-3H3,(H2,24,25)(H2,26,27,28,29) | | Definition date: | 2013-11-08 | | Last modified: | 2013-11-15 | | Release date: | 2013-11-20 | | Identifier: | 1-[4-(1-aminoisoquinolin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea |
|
 | | 15O | | Name: | 1-chloronaphthalene | | Formula: | C10 H7 Cl | | SMILES: | Clc2cccc1ccccc12 | | InChi: | InChI=1S/C10H7Cl/c11-10-7-3-5-8-4-1-2-6-9(8)10/h1-7H | | Definition date: | 2012-10-15 | | Last modified: | 2013-10-11 | | Release date: | 2013-10-16 | | Identifier: | 1-chloronaphthalene |
|
 | | 1QO | | Name: | N-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine | | Formula: | C16 H14 N4 | | SMILES: | n1c(ccnc1NCc2ccccc2)c3cccnc3 | | InChi: | InChI=1S/C16H14N4/c1-2-5-13(6-3-1)11-19-16-18-10-8-15(20-16)14-7-4-9-17-12-14/h1-10,12H,11H2,(H,18,19,20) | | Definition date: | 2013-04-27 | | Last modified: | 2013-09-13 | | Release date: | 2013-09-18 | | Identifier: | N-benzyl-4-(pyridin-3-yl)pyrimidin-2-amine |
|
 | | LTZ | | Name: | (5R,6S)-2-[((2S,5R)-2-{[(3R)-4-acetyl-3-methylpiperazin-1-yl]carbonyl}-5-ethylpyrrolidin-1-yl)carbonyl]-5,6-bis(4-chlorophenyl)-3-isopropyl-6-methyl-5,6-dihydroimidazo[2,1-b][1,3]thiazole | | Formula: | C36 H43 Cl2 N5 O3 S | | SMILES: | O=C(N6C(C)CN(C(=O)C5N(C(=O)C=3SC4=NC(c1ccc(Cl)cc1)(C(c2ccc(Cl)cc2)N4C=3C(C)C)C)C(CC)CC5)CC6)C | | InChi: | InChI=1S/C36H43Cl2N5O3S/c1-7-28-16-17-29(33(45)40-18-19-41(23(5)44)22(4)20-40)42(28)34(46)31-30(21(2)3)43-32(24-8-12-26(37)13-9-24)36(6,39-35(43)47-31)25-10-14-27(38)15-11-25/h8-15,21-22,28-29,32H,7,16-20H2,1-6H3/t22-,28-,29+,32-,36+/m1/s1 | | Definition date: | 2013-02-19 | | Last modified: | 2013-05-31 | | Release date: | 2013-06-05 | | Identifier: | 1-[(2R)-4-{[(2S,5R)-1-{[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-(propan-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazol-2-yl]carbonyl}-5-ethylpyrrolidin-2-yl]carbonyl}-2-methylpiperazin-1-yl]ethanone |
|
 | | 814 | | Name: | [(3R,5S,6R,7R,11S,12Z,14E)-5,11,21-trimethoxy-3,7,9,15-tetramethyl-6-oxidanyl-16,20,22-tris(oxidanylidene)-19-phenyl-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate | | Formula: | C35 H44 N2 O9 | | SMILES: | CO[CH]1C[CH](C)CC2=C(OC)C(=O)C(=C(NC(=O)C(=CC=C[CH](OC)[CH](OC(N)=O)C(=C[CH](C)[CH]1O)C)C)C2=O)c3ccccc3 | | InChi: | InChI=1S/C35H44N2O9/c1-19-16-24-30(39)28(27(31(40)33(24)45-7)23-13-9-8-10-14-23)37-34(41)20(2)12-11-15-25(43-5)32(46-35(36)42)22(4)18-21(3)29(38)26(17-19)44-6/h8-15,18-19,21,25-26,29,32,38H,16-17H2,1-7H3,(H2,36,42)(H,37,41)/b15-11-,20-12+,22-18+/t19-,21-,25+,26+,29-,32-/m1/s1 | | Definition date: | 2012-05-01 | | Last modified: | 2012-09-12 | | Release date: | 2013-04-03 | | Identifier: | [(3R,5S,6R,7R,11S,12Z,14E)-5,11,21-trimethoxy-3,7,9,15-tetramethyl-6-oxidanyl-16,20,22-tris(oxidanylidene)-19-phenyl-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate |
|
 | | 0X1 | | Name: | (5-hydroxy-6-methyl-4-{[(1-oxo-7-phenoxy-1,2-dihydro[1,2,4]triazolo[4,3-a]quinolin-4-yl)amino]methyl}pyridin-3-yl)methyl dihydrogen phosphate | | Formula: | C24 H22 N5 O7 P | | SMILES: | O=P(O)(O)OCc1cnc(c(O)c1CNC2=Cc5c(N3C(=O)NN=C23)ccc(Oc4ccccc4)c5)C | | InChi: | InChI=1S/C24H22N5O7P/c1-14-22(30)19(16(11-25-14)13-35-37(32,33)34)12-26-20-10-15-9-18(36-17-5-3-2-4-6-17)7-8-21(15)29-23(20)27-28-24(29)31/h2-11,26,30H,12-13H2,1H3,(H,28,31)(H2,32,33,34) | | Definition date: | 2012-08-16 | | Last modified: | 2012-08-24 | | Release date: | 2012-08-24 | | Identifier: | (5-hydroxy-6-methyl-4-{[(1-oxo-7-phenoxy-1,2-dihydro[1,2,4]triazolo[4,3-a]quinolin-4-yl)amino]methyl}pyridin-3-yl)methyl dihydrogen phosphate |
|
 | | ZY3 | | Name: | N-{(1S,2R)-1-BENZYL-2-HYDROXY-3-[(3-METHOXYBENZYL)AMINO]PROPYL}-6-(ETHYLAMINO)-1-METHYL-1,3,4,5-TETRAHYDRO-2,1-BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE | | Formula: | C31 H40 N4 O5 S | | SMILES: | O=C(c1cc2c(c(NCC)c1)CCCS(=O)(=O)N2C)NC(Cc3ccccc3)C(O)CNCc4cccc(OC)c4 | | InChi: | InChI=1S/C31H40N4O5S/c1-4-33-27-18-24(19-29-26(27)14-9-15-41(38,39)35(29)2)31(37)34-28(17-22-10-6-5-7-11-22)30(36)21-32-20-23-12-8-13-25(16-23)40-3/h5-8,10-13,16,18-19,28,30,32-33,36H,4,9,14-15,17,20-21H2,1-3H3,(H,34,37)/t28-,30+/m0/s1 | | Definition date: | 2009-04-02 | | Last modified: | 2011-06-04 | | Identifier: | N-{(1S,2R)-1-benzyl-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}-6-(ethylamino)-1-methyl-1,3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide |
|
 | | OXY | | Name: | OXYGEN MOLECULE | | Formula: | O2 | | SMILES: | O=O | | InChi: | InChI=1S/O2/c1-2 | | Definition date: | 1999-07-08 | | Last modified: | 2011-06-04 | | Identifier: | molecular oxygen |
|
 | | DMM | | Name: | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN | | Formula: | C32 H37 N O13 | | SMILES: | O=C2c1c(O)c6c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC6OC5OC(C)C(O)C(N4CCOC(OC)C4)C5 | | InChi: | InChI=1S/C32H37NO13/c1-14-27(36)17(33-7-8-44-22(12-33)43-3)9-21(45-14)46-19-11-32(41,20(35)13-34)10-16-24(19)31(40)26-25(29(16)38)28(37)15-5-4-6-18(42-2)23(15)30(26)39/h4-6,14,17,19,21-22,27,34,36,38,40-41H,7-13H2,1-3H3/t14-,17-,19-,21-,22-,27+,32-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2011-06-04 | | Identifier: | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside |
|
